0001437749-19-015054.txt : 20190731
0001437749-19-015054.hdr.sgml : 20190731
20190731163515
ACCESSION NUMBER: 0001437749-19-015054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190522
FILED AS OF DATE: 20190731
DATE AS OF CHANGE: 20190731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morton Mawae
CENTRAL INDEX KEY: 0001715607
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14602
FILM NUMBER: 19989227
MAIL ADDRESS:
STREET 1: 7473 MAKA'A STREET
CITY: HONOLULU
STATE: HI
ZIP: 96825
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYANOTECH CORP
CENTRAL INDEX KEY: 0000768408
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 911206026
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 73-4460 QUEEN KAAHUMANU HWY
STREET 2: SUITE 102
CITY: KAILUA KONA
STATE: HI
ZIP: 96740
BUSINESS PHONE: 8083261353
MAIL ADDRESS:
STREET 1: 73-4460 QUEEN KAAHUMANU HWY
STREET 2: SUITE 102
CITY: KAILUA-KONA
STATE: HI
ZIP: 96740
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-05-22
0000768408
CYANOTECH CORP
CYAN
0001715607
Morton Mawae
73-4460 QUEEN KAAHUMANU HWY #102
KAILUA-KONA
HI
96740
1
Former CEO and Director
Common Stock
2019-07-15
4
A
0
11400
0
A
13015
D
Common Stock
2019-07-15
4
D
0
4104
0
D
8911
D
Common Stock
2019-05-22
4
M
0
1993
0
A
2026
D
Common Stock
2019-05-22
4
M
0
411
0
D
1615
D
Restricted Stock Units
2019-05-22
4
M
0
1993
0
D
Common Stock
1993
0
D
Stock Options
3.3500
Common Stock
75000
75000
D
Stock Options
3.8300
Common Stock
45000
45000
D
Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder.
Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder.
Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock.
Pursuant to Separation Agreement, all restricted stock units are fully vested as of May 22, 2019.
Pursuant to Separation Agreement, all stock options are fully vested as of May 22, 2019.
Pursuant to Separation Agreement, all stock options will expire on December 6, 2019.
/s/ Jesse Debban, by Power of Attorney
2019-07-31